The Health Ministry on Monday granted an exceptional and provisional marketing authorisation on the Tunisian market to the Chinese COVID-19 vaccine Sinopharm.

The authorisation was granted following a study of the file by the committee of experts in virology and toxicology, and the technical committee of pharmacology, the Ministry said in a statement.

Source: TAP News Agency